Director of Search & Evaluation, Business Development

At Medison, we offer hope to patients suffering from rare and severe diseases. Through strategic partnerships with best-in-class biotech companies we commercialize innovative therapies across global markets.

Medison is a dynamic, fast‑paced company operating in dozens of countries across five continents. We are looking for passionate, agile, and adaptive leader who want to make a real impact and help shape the future of global healthcare. Our culture is rooted in care, agility, collaboration, and innovation, and we’re united by a shared purpose to make a meaningful difference.

If you’re passionate about driving growth and delivering breakthrough innovation to patients, we invite you to be part of our journey.

Reporting to Medison’s Head of Business Development, the Director, Search & Evaluation Business Development is a mission‑critical leadership role that directly shapes Medison’s long‑term growth and strategic direction, while advancing our core purpose of improving and saving patients’ lives worldwide. The position plays a foundational role in building Medison’s future pipeline by identifying high‑impact opportunities that expand global access to the most advanced therapies.

In this role, you will proactively identify best‑in‑class assets, lead rigorous scientific and clinical evaluations, and drive cross‑functional diligence to enable high‑quality, strategic partnering decisions. You will operate at the intersection of science, strategy, and execution, working in close partnership with Medical, Regulatory, and senior leadership to support disciplined growth and long‑term value creation.

• An advanced degree in Life Sciences (PhD or MD) is required; an MBA or additional business training is a strong advantage.

• At least eight years of relevant experience in Search and Evaluation, Business Development, Licensing, Corporate Development, venture capital, or related partnering roles within pharma or biotech.

• Proven experience evaluating late‑stage assets from Phase 2 through marketed products, preferably in rare and severe diseases.

• Strong understanding of drug development, clinical data interpretation, regulatory pathways, and competitive dynamics.

• Demonstrated experience developing Target Product Profiles and comparing clinical data to existing standards of care.

• Proven ability to lead cross‑functional diligence teams and work closely with Business Development deal leads throughout the transaction lifecycle.

• Strong scientific credibility with the ability to engage confidently with Key Opinion Leaders, investigators, and senior internal stakeholders.

• Excellent written and verbal communication skills in English, with the ability to create clear, concise, executive‑level decision materials.

• Strong organizational skills and the ability to manage multiple complex evaluations in parallel in a fast‑paced environment.

• An ownership‑driven, hands‑on leadership style with strong strategic thinking, sound judgment, and business acumen.